PharmaVentures has announced its agreement with Growthink Research, the US-based market research company, to distribute the Growthink Research Venture Capital database to PharmaVentures' customers worldwide.

Oxford Science Park, Oxford (PRWEB) May 21, 2008 -- PharmaVentures announced today an agreement with Growthink Research, the US-based market research firm, to distribute its Venture Capital database to customers in industry and academic institutions worldwide. Fintan Walton, PhD, PharmaVentures' Chief Executive Officer, says, "As experts in deals and alliances in the pharmaceutical and biotechnology sector, we have in-depth knowledge of the workflows and information needs of business development and licensing executives. Access to comprehensive and reliable financial data is vital, and we are delighted to have forged this partnership to complement our own proprietary PharmaDeals® v2 database."

Corey Lavinsky, CEO for Growthink Research adds, "In our work analyzing venture capital activity, we have carefully tracked over 8,800 US-based, venture-funded companies, many within the bioscience industry. Our data is an invaluable resource for companies looking to raise capital or to identify new clients. Working with PharmaVentures will help us target new markets internationally that have a strong and persistent demand for this high quality financial information."

The new agreement with Growthink Research, and PharmaVentures' rapid development of its PharmaDeals database, analytical services and customer services, underpins PharmaVentures' drive to provide information solutions to its customers in top pharmaceutical and biotechnology companies. Anne Vindenes Allen, PharmaDeals' Chief Operating Officer says, "Unlike many generic database providers, we have the expertise in-house to work with our customers to solve specific business issues. Growthink Research's venture capital database, along with our own new services, is another milestone along this track that will help our customers in their decision-making and effectiveness."

About PharmaVentures
PharmaVentures (www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making. The Company's core business is the provision of tailored transaction advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals® range of publishing products that include databases, analysis tools, and reports. PharmaVentures is based in Oxford, UK, and employs over 35 people. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.

http://www.pharmaventures.com
http://www.pharmadeals.net
http://www.pharmatelevision.com

About Growthink Research
Growthink Research is a market research firm that specializes in tracking and analyzing venture captial activity. Its proprietary venture capital database has detailed information on over 8,800 U.S.-based, venture-funded companies, over 17,000 funding transactions and over 90,000 executives, directors and advisors. Companies seeking captial, venture capital firms, investment bankers, and service providers rely on Growthink Research to raise capital, identify and secure new clients, and gain competitive intelligence.

Corey Lavinsky
Growthink Research
28 S. Venice Blvd.
Suite S
Venice, CA 90291
(310) 823-8346
corey(at)growthinkresearch.com

http://www.growthinkresearch.com

To sign up for future press releases from PharmaVentures, please contact:
Lisa Holloway
PharmaDeals Marketing
PharmaVentures Ltd.
Magdalen Centre
Oxford Science Park
Oxford, OX4 4GA
UK

Tel: +44 (0) 1865 784 177
Fax: +44 (0) 1865 784 178
Email: lisa.holloway(at)pharmaventures.com
Web site: http://www.pharmaventures.com

PharmaDeals is a registered trade mark of PharmaVentures Ltd.

###

Simillar Articles

PharmaVentures Helps Deal-Making Through Beta Launch Of Its PharmaDeals® v2 Database

PharmaVentures, the transaction advisory and media company, announced today the launch of its new product, PharmaDeals v2, a database of deals and alliances for the pharmaceuticals and...

Determining Valuations in Challenging Times

In today's financial climate, the survival of smaller companies is often dependent on their ability to do deals successfully with larger pharmaceutical companies. The Royalty Rate Report 2009:...

Major New Report Highlights Growing Importance of IP Strategies and Competition Law in the...

PharmaVentures announced today the publication of the report 'Competition Law and Intellectual Property Strategy in the Pharmaceuticals Sector', written by Richard Eccles and Gerry...

PharmaVentures Acted As Advisor For Sale of PhotoBioChem, N.V. Patent Assets to SpectraCure, AB

PharmaVentures announced today that it had acted as an advisor and broker to the PhotoBioChem, N.V. Holland for the sale of its patent assets to SpectraCure AB, Sweden.

PharmSource Introduces Proprietary Resource for Identifying New Business Opportunities in Bio/Pharma

PharmSource Lead Sheet upgrades database resources to help companies serving biotech/pharma industry to find new business opportunities and market intelligence.

Home